{"nct_id":"NCT01393106","title":"Safety and Efficacy of Idelalisib in Relapsed or Refractory Hodgkin Lymphoma","status":"COMPLETED","status_verified_date":"2015-11","start_date":"2011-09","start_date_type":null,"primary_completion_date":"2014-08","primary_completion_date_type":"ACTUAL","completion_date":"2014-08","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GILD"]}